GETUG-AFU 25/PEACE 3: Personalized treatment of patients with metastatic castrate-resistant prostate cancer (MCRPC) receiving docetaxel, using either early switch to cabazitaxel or maintenance treatment with docetaxel plus radium-223, based on circulating tumor cell (CTCs) enumeration.
Centre François Baclesse , Institut Curie , Centre Eugène Marquis , Centre René Gauducheau , Institut Paoli-Calmettes- (IPC) , Centre Hospitalier de Mont-de-Marsan , Centre Antoine Lacassagne , Clinique Sainte Marguerite , Centre Léon Bérard , Hôpital Saint-Louis , Institut Jean Godinot , Hôpital Saint Joseph , Hôpital Édouard Herriot , Institut Gustave Roussy , Institut de Cancérologie de l'Ouest
Start a new DMP in Loading
Centre François Baclesse , Institut Curie , Centre Eugène Marquis , Centre René Gauducheau , Institut Paoli-Calmettes- (IPC) , Centre Hospitalier de Mont-de-Marsan , Centre Antoine Lacassagne , Clinique Sainte Marguerite , Centre Léon Bérard , Hôpital Saint-Louis , Institut Jean Godinot , Hôpital Saint Joseph , Hôpital Édouard Herriot , Institut Gustave Roussy , Institut de Cancérologie de l'Ouest
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=inca________::3ac9160c69db47d0007c56d558a7243b&type=result"></script>');
-->
</script> For further information contact us at helpdesk@openaire.eu